Resources - Search Results | Barrington James

Back to resources

Displaying 1 - 8 of 121

Strategic Solutions Group
Building out Site Research Capabilities: A Barrington James Perspective
The clinical research industry is experiencing a pivotal shift. Increasingly complex protoco...

By Bryan Katz July 21st, 2025
Strategic Solutions Group
Why Sponsors Are Rethinking the CRO Status Quo?
CRO Slowdown and Rising Pressures.Clinical development leaders are facing a perfect storm of...

By Barrington James July 15th, 2025
Company News
Merck to Acquire Verona Pharma for $10 Billion, Adding Breakthrough COPD Drug Ohtuvayre
The deal in detailIn this agreement, Merck will pay $107 each American Depository Share, val...

By Barrington James July 9th, 2025
Strategic Solutions Group
Taking Control: Driving Efficiency and Innovation with Embedded, In-House Clinical Trial Teams
Never has a pharma or biotech’s use of capital been under more scrutiny. Consequently, regar...

By Bryan Katz July 1st, 2025
Company News, Pharmaceutical
The Rise and Growth of Antibody-Drug Conjugates in Cancer Treatment.
Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...

By Barrington James June 18th, 2025
Company News
£86 Billion UK Science & Tech Investment: What It Means for Life Science
The UK’s record £86 billion R&D pledge (worth £22.5 billion a year by FY 2029/30) will f...

By Barrington James June 9th, 2025
Company News
APAC Life Science Executive Search | Nicholas Sim
As APAC Managing Partner at Board & Executive Partners (a Barrington James com...

By Nicholas Sim May 28th, 2025
Medical Device
APAC Contract Life Science Recruitment | Xuan Bin See
Singapore's strategic position at the heart of Asia-Pacific and it's deep pool of scientific...

By Barrington James May 26th, 2025